SCHEMBL3340108

SCHEMBL3340108

CC/C(C)=C/CCC(C)CCO

nearest known ligand 0.67

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.67
ALDH1A1 P00352 1/20 0.67
PTPN1 P18031 1/20 0.35
SQLE Q14534 3/20 0.32
USP2 O75604 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23882546 1.00 ALOX15 (0.67) ALOX15ALDH1A1PTPN1SQLEUSP2
SCHEMBL3340110 1.00 ALOX15 (0.67) ALOX15ALDH1A1PTPN1SQLEUSP2
SCHEMBL23882535 1.00 ALOX15 (0.67) ALOX15ALDH1A1PTPN1SQLEUSP2
SCHEMBL23882536 1.00 ALOX15 (0.67) ALOX15ALDH1A1PTPN1SQLEUSP2
SCHEMBL23882548 1.00 ALOX15 (0.67) ALOX15ALDH1A1PTPN1SQLEUSP2
SCHEMBL23882538 1.00 ALOX15 (0.67) ALOX15ALDH1A1PTPN1SQLEUSP2
Acetic Acid SCHEMBL21903090 0.93 ALOX15 (0.58) ALOX15ALDH1A1PTPN1USP2TSHR
SCHEMBL15571282 0.85 ALOX15 (0.69) ALOX15ALDH1A1PTPN1SQLEUSP2
SCHEMBL15571280 0.85 ALOX15 (0.69) ALOX15ALDH1A1PTPN1SQLEUSP2
SCHEMBL28189394 0.85 ALOX15 (0.69) ALOX15ALDH1A1PTPN1SQLEUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4734932-A1 ORGANIC COMPOUNDS AND THEIR USE FOR GENERATING A FRAGRANT ALCOHOL Givaudan SA (CH) 2026-05-06 EP claimed
WO-2025003204-A1 ORGANIC COMPOUNDS AND THEIR USE FOR GENERATING A FRAGRANT ALCOHOL GIVAUDAN SA (CH) 2025-01-02 WO claimed
EP-4734932-A1 ORGANIC COMPOUNDS AND THEIR USE FOR GENERATING A FRAGRANT ALCOHOL Givaudan SA (CH) 2026-05-06 EP disclosed
US-20260096991-A1 BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION XAMPLA LTD (GB) 2026-04-09 US disclosed
EP-4489592-B1 BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION XAMPLA LTD (GB) 2025-12-24 EP disclosed
US-12492158-B2 (S,Z)-3,7-dimethylnon-6-en-1-ol and its use as fragrance GIVAUDAN SA (CH) 2025-12-09 US disclosed
US-20250255827-A1 BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION XAMPLA LIMITED (GB) 2025-08-14 US disclosed
EP-4593639-A1 BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION Xampla Limited (GB) 2025-08-06 EP disclosed
US-20250236576-A1 PROCESS GIVAUDAN SA (CH) 2025-07-24 US disclosed
US-20250186960-A1 BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION XAMPLA LIMITED (GB) 2025-06-12 US disclosed
EP-3888782-B1 COATED MICROCAPSULES NOXELL CORP (US) 2025-06-11 EP disclosed
US-20150351519-A1 Articles Providing Long Lasting Fragrances THE PROCTER & GAMBLE COMPANY 2015-12-10 US disclosed
US-20150353867-A1 Articles Providing Long Lasting Fragrances THE PROCTER & GAMBLE COMPANY 2015-12-10 US disclosed
US-20150352578-A1 Flushing Dispensers For Delivering A Consistent Consumer Experience THE PROCTER & GAMBLE COMPANY 2015-12-10 US disclosed
US-20150354550-A1 Flushing Dispensers For Delivering A Consistent Consumer Experience THE PROCTER & GAMBLE COMPANY 2015-12-10 US disclosed
US-20150352577-A1 Dispensers For Delivering A Consistent Consumer Experience THE PROCTER & GAMBLE COMPANY 2015-12-10 US disclosed
US-20150352575-A1 Articles Providing Long Lasting Fragrances THE PROCTER & GAMBLE COMPANY 2015-12-10 US disclosed
EP-2366014-B1 PERFUME SYSTEMS PROCTER & GAMBLE (US) 2015-11-04 EP disclosed
US-8754028-B2 Perfume systems THE PROCTER & GAMBLE COMPANY (US) 2014-06-17 US disclosed
US-20100152083-A1 Perfume Systems PROCTER & GAMBLE COMPANY, THE 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260096991-A1 BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION PCTP, CLK4, MTCL3 ALOX15 4169/4885ALDH1A1 4813/4885PTPN1 3562/4885
US-20250236576-A1 PROCESS PPOX, CYB5R3, POR ALOX15 20/4885ALDH1A1 178/4885PTPN1 4548/4885
US-12492158-B2 (S,Z)-3,7-dimethylnon-6-en-1-ol and its use as fragrance CYP51A1, DEGS1, ALG3 ALOX15 27/4885ALDH1A1 83/4885PTPN1 4664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.